Restricted accessResearch articleFirst published online 2011-11
A Myocardial Patch Made of Collagen Membranes Loaded with Collagen-Binding Human Vascular Endothelial Growth Factor Accelerates Healing of the Injured Rabbit Heart
Tissue-engineered myocardial patches could be useful in the repair of myocardial injuries. The aim of the present study was to evaluate a collagen targeting delivery system for myocardial repair. A specific peptide collagen-binding domain (CBD) was fused to human vascular endothelial growth factor (VEGF) to enhance the binding of VEGF to collagen. In this study, collagen membranes loaded with CBD-VEGF, natural VEGF, or phosphate-buffered saline are used as cardiac patches to repair the infarcted myocardium in a rabbit model. CBD-VEGF/collagen group could effectively induce more cells to penetrate into the collagen membrane after 4 weeks and promote more vascularization in infarcted myocardium after 12 weeks compared with the other two control groups. Echocardiography and hemodynamic studies both show cardiac function improvement in the CBD-VEGF/collagen group. These results reveal that implantation of CBD-VEGF collagen membrane patch into the infarcted myocardium could effectively improve left ventricle cardiac function and increase the vascular density.
Get full access to this article
View all access options for this article.
References
1.
WHO. The Top 10 Causes of Death. Geneva, Switzerland: WHO, 2004.
2.
FukudaS., YoshiiS., KagaS., MatsumotoM., KugiyamaK., MaulikN.Angiogenic strategy for human ischemic heart disease: brief overview. Mol Cell Biochem, 264:143. 2004.
3.
HaradaK., FriedmanM., LopezJ.J., WangS.Y., LiJ., PrasadP.V.et al.Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol, 270:H1791. 1996.
OzawaC.R., BanfiA., GlazerN.L., ThurstonG., SpringerM.L., KraftP.E.et al.Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest, 113:516. 2004.
6.
ChristmanK.L., LeeR.J.Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol, 48:907. 2006.
DavisM.E., HsiehP.C., GrodzinskyA.J., LeeR.T.Custom design of the cardiac microenvironment with biomaterials. Circ Res, 97:8. 2005.
9.
KolacnaL., BakesovaJ., VargaF., KostakovaE., PlankaL., NecasA.et al.Biochemical, biophysical aspects of collagen nanostructure in the extracellular matrix. Physiol Res., 56,Suppl 1:S51. 2007.
10.
JugduttB.I.Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?Circulation, 108:1395. 2003.
11.
BoccafoschiF., HabermehlJ., VesentiniS., MantovaniD.Biological performances of collagen-based scaffolds for vascular tissue engineering. Biomaterials, 26:7410. 2005.
12.
SumitaY., HondaM.J., OharaT., TsuchiyaS., SagaraH., KagamiH.et al.Performance of collagen sponge as a 3-D scaffold for tooth-tissue engineering. Biomaterials, 27:3238. 2006.
ChenW., ShiC., YiS., ChenB., ZhangW., FangZ.et al.Bladder regeneration by collagen scaffolds with collagen binding human basic fibroblast growth factor. J Urol, 183:2432. 2010.
15.
FujitaM., MorimotoY., IshiharaM., ShimizuM., TakaseB., MaeharaT.et al.A new rabbit model of myocardial infarction without endotracheal intubation. J Surg Res, 116:124. 2004.
16.
HsiehP.C., MacGillivrayC., GannonJ., CruzF.U., LeeR.T.Local controlled intramyocardial delivery of platelet-derived growth factor improves postinfarction ventricular function without pulmonary toxicity. Circulation, 114:637. 2006.
17.
YangY., ZhaoY., ChenB., HanQ., SunW., XiaoZ.et al.Collagen-binding human epidermal growth factor promotes cellularization of collagen scaffolds. Tissue Eng Part A, 15:3589. 2009.
18.
ChenL., HeZ., ChenB., YangM., ZhaoY., SunW.et al.Loading of VEGF to the heparin cross-linked demineralized bone matrix improves vascularization of the scaffold. J Mater Sci Mater Med, 21:309. 2010.
19.
LeorJ., AmsalemY., CohenS.Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol Ther, 105:151. 2005.
20.
RatnerB.D., BryantS.J.Biomaterials: where we have been and where we are going. Annu Rev Biomed Eng, 6:41. 2004.
21.
SilvaE.A., MooneyD.J.Synthetic extracellular matrices for tissue engineering and regeneration. Curr Top Dev Biol, 64:181. 2004.
ZhaoT., ZhaoW., ChenY., AhokasR.A., SunY.Vascular endothelial growth factor (VEGF)-A: role on cardiac angiogenesis following myocardial infarction. Microvasc Res, 80:188. 2010.
27.
BeardD.A., BassingthwaighteJ.B.Modeling advection and diffusion of oxygen in complex vascular networks. Ann Biomed Eng, 29:298. 2001.
28.
ZuurbierC.J., van ItersonM., InceC.Functional heterogeneity of oxygen supply-consumption ratio in the heart. Cardiovasc Res, 44:488. 1999.
29.
NomiM., MiyakeH., SugitaY., FujisawaM., SokerS.Role of growth factors and endothelial cells in therapeutic angiogenesis and tissue engineering. Curr Stem Cell Res Ther, 1:333. 2006.
30.
FrerichB., LindemannN., Kurtz-HoffmannJ., OertelK.In vitro model of a vascular stroma for the engineering of vascularized tissues. Int J Oral Maxillofac Surg, 30:414. 2001.
31.
BarandonL., CouffinhalT., DufourcqP., EzanJ., CostetP., DaretD.et al.Frizzled A. a novel angiogenic factor: promises for cardiac repair. Eur J Cardiothorac Surg, 25:76. 2004.
32.
NelsonM.A., PasseriJ., FrishmanW.H.Therapeutic angiogenesis: a new treatment modality for ischemic heart disease. Heart Dis, 2:314. 2000.
KedemA., PeretsA., Gamlieli-BonshteinI., Dvir-GinzbergM., MizrahiS., CohenS.Vascular endothelial growth factor-releasing scaffolds enhance vascularization and engraftment of hepatocytes transplanted on liver lobes. Tissue Eng, 11:715. 2005.
39.
SmithM.K., RiddleK.W., MooneyD.J.Delivery of hepatotrophic factors fails to enhance longer-term survival of subcutaneously transplanted hepatocytes. Tissue Eng, 12:235. 2006.
40.
LassoJ.M., Del RioM., GarciaM., Martinez CallejaV., NavaP., Munoz-FernandezM.A.et al.Improving flap survival by transplantation of a VEGF-secreting endothelised scaffold during distal pedicle flap creation. J Plast Reconstr Aesthet Surg, 60:279. 2007.
41.
LinH., ChenB., SunW., ZhaoW., ZhaoY., DaiJ.The effect of collagen-targeting platelet-derived growth factor on cellularization and vascularization of collagen scaffolds. Biomaterials, 27:5708. 2006.
42.
SunW., SunC., LinH., ZhaoH., WangJ., MaH.et al.The effect of collagen-binding NGF-beta on the promotion of sciatic nerve regeneration in a rat sciatic nerve crush injury model. Biomaterials, 30:4649. 2009.
43.
HanQ., SunW., LinH., ZhaoW., GaoY., ZhaoY.et al.Linear ordered collagen scaffolds loaded with collagen-binding brain-derived neurotrophic factor improve the recovery of spinal cord injury in rats. Tissue Eng Part A, 15:2927. 2009.
44.
LiangW., HanQ., JinW., XiaoZ., HuangJ., NiH.et al.The promotion of neurological recovery in the rat spinal cord crushed injury model by collagen-binding BDNF. Biomaterials, 31:8634. 2010.
45.
Fontes-SousaA.P., MouraC., CarneiroC.S., Teixeira-PintoA., AreiasJ.C., Leite-MoreiraA.F.Echocardiographic evaluation including tissue Doppler imaging in New Zealand white rabbits sedated with ketamine and midazolam. Vet J, 181:326. 2009.
46.
Yamaoka-TojoM., Ushio-FukaiM., HilenskiL., DikalovS.I., ChenY.E., TojoT.et al.IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species—dependent endothelial migration and proliferation. Circ Res, 95:276. 2004.
47.
DaviesN., DobnerS., BezuidenhoutD., SchmidtC., BeckM., ZischA.H.et al.The dosage dependence of VEGF stimulation on scaffold neovascularisation. Biomaterials, 29:3531. 2008.
